Sanofi earnings rise 15% on strength in top drugs

Article Abstract:

Sanofi-Aventis S.A. of France posted a 15 percent increase in net profit for the second quarter to 1.79 billion Euros ($2.3 billion) from 1.55 billion Euros last year. Net sales were up 5.9 percent to 7.08 billion Euros form 6.69 billion Euros last year. Revenues were due to increased market share of pharmaceuticals and cost cutting measures.

France

---

Sanofi profit falls as generic drugs of rivals take toll

Article Abstract:

Sanofi-Aventis S.A. posted a net profit drop of 4.6 percent for the fourth quarter to 1.38 billion Euros ($1.8 billion) from 1.44 billion Euros last year. Overall sales rose 5 percent to 7.36 billion Euros on the strength of the antithrombotic medication Lovenox.

Financial report

---

Sanofi's profit drops 12%: drug firm pressured by rivals, overhauls in France, Germany

Article Abstract:

French pharmaceutical company Sanofi-Aventis S.A. is reporting a drop of 12% in third-quarter net profit. Competition from generic drugs, flu vaccine delays, and changes in the health care system in France and Germany are being blamed for the losses.

Similar abstracts:

• Abstracts: Swisscom gets approval for foreign takeovers. Deutsche Telekom profit falls 87% on taxes, costs. EU to rule on plan for accessing Deutsche Telekom's new network
• Abstracts: Glaxo plans to trim jobs as profit falls. Glaxo expects earnings to fall in 2008
• Abstracts: Starbucks earnings rise 16 percent; wait time curbs sales growth. Heinz to cut jobs, spend less as profit drops 19%
• Abstracts: Santander net rises 26%. Santander boosts profit with asset sales, lending
• Abstracts: Porsche warns of profit decline for the fiscal year. Dresdner Bank confirms outlook but warns of weaker second half

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.